fused to the SMN binding protein Gemin2 (GST-Gemin2) ingly, only the symmetrically methylated RG peptides bound SMN, indicating that native SMN binds preferenwas used as a positive control, and GST alone was used as a negative control. Retained proteins were resolved tially to symmetrically dimethylated SmD1 and SmD3 in cell extracts. by SDS-PAGE, Western blotted onto a membrane, and probed with the SMN-specific antibody 2B1 ( Figure 1A) .
To further investigate SMN binding to sDMA-modified targets, His-tagged SMN bound to Gemin2 (Gemin2/HisDespite the fact that recombinant SMN binds directly to these recombinant Sm proteins and their carboxy-SMN) was tested for direct interaction with immobilized SmD3 peptides (Figure 2A To obtain a more quantitative estimate of the difference in SMN's (Biotin-D1c29-sDMA and Biotin-D3c32-sDMA) the specific sDMA modifications formed in vivo, were syntheaffinity for sDMA-modified versus unmodified RG peptide, increasing amounts of immobilized GST-Gemin2/ sized ( Figure 1B) . As an additional control a D3c32 peptide (Biotin-D3c32-aDMA) with aDMA in place of sDMA His-SMN were incubated with a constant amount of each peptide which had been radiolabeled by preincuwas also synthesized. Each peptide or biotin alone was immobilized on streptavidin sepharose and used for bation with [ Figure 3B ). Four bands of the same molecular mass as those whose SMN binding is reduced by SmD1 and SmD3 (and therefore possibly SmB) has been shown to affect their reactivity with these antibodies hypomethylation (p120, p100, p72, and p22) were observed, demonstrating that these four proteins do in- (Brahms et al., 2000) . Anti-SMN antibody (2B1) immunoprecipitated similar amounts of SMN and Gemin2 from deed receive methylation. These results demonstrate that, in addition to SmD1 and SmD3, SMN binds preferuntreated or Adox-treated cells. In contrast, 2B1 coimmunoprecipitated significantly less myc-D3 from Adoxentially to other proteins after they are posttranslationally methylated. treated cells than from untreated cells, supporting the conclusion that arginine methylation of SmD3 is required for (or at least strongly enhances) its interaction with Discussion SMN.
In addition to Sm proteins, SMN interacts with many The results presented here establish the mechanism by which SMN, the product of the SMA disease gene, other RGG domain-containing proteins, including fibrillarin, hnRNP U (Liu and Dreyfuss, 1996), and RNA helirecognizes its targets, and demonstrate a novel molecular function for dimethylation of arginines. SMA is one case A (Pellizzoni et al., 2001) , 2000) , and arginine methylation now emerges as a new mechanism for enhancing SMN substrate selection. Our view that protein arginine methylation is a general mechanism by which high-affinity Sm protein substrates are generated and targeted to the SMN complex is presented in Figure  4 . It illustrates our understanding of the role of methylation of Sm proteins in promoting their interaction with SMN. This is presently the best-characterized interac- ., 2000) . However, the position and indeed even whether these undermethylation of proteins that interact with SMN, such as SmD1 and SmD3, would likely also be particuproline-rich ligands receive dimethylation of arginines is not known, making the physiological relevance of this larly deleterious to these cells. Thus, deficiencies in protein arginine methylations may need to be considered in finding uncertain. Our demonstration of selective interaction of SMN with dimethylarginine-modified proteins the context of human disease, especially those involving the nervous system. Interestingly, the nervous system suggests a novel mode of protein-protein interaction. The dimethylated arginines must form a unique surface has long been known to be particularly sensitive to folate and vitamin B12 deficiencies, both of which are required that mediates the interaction of the RG domain with SMN. It will be of great interest to determine the structure for maintaining the SAM-dependent protein methylation cycle (Scott, 1999) In summary, we show that methylation of arginines can ylation of proteins would further aggravate the severity of SMA. This raises the possibility that it may be advispromote specific protein-protein interactions. We further suggest that arginine methylation is a key to subable to consider adequate supplementation with factors domain of the IFNAR1 chain in the type I interferon receptor. EMBO
